Tanke Biosciences Corporation

Tanke Biosciences Corporation

TNBI - Insider Information

Get informed when a big investor buys or sells

+ Follow
Market Cap$509.29K
Close$

Compare to Similar Companies

P/E RatioDividendsReturn on EquityPrice-to-SalesDebt-to-Equity
Tanke Biosciences CorporationTanke Biosciences Corporation-2.6-35%--0.3
$-0.00

Current Fair Value

111.5% downside

Overvalued by 111.5% based on the discounted cash flow analysis.

Insider Trades

Loading insider trades…

Congress Trades

Loading congress trades…

Share Statistics

Market cap$509,286.00
Enterprise Value$646,071.00
Earnings per Share$-0.01
Beta-1.05
Outstanding Shares25,464,279

Return

Return on Equity34.62%ROE
Return on Assets-258.27%
Return on Invested Capital32.64%

Valuation & Multiples

P/E Ratio-2.63P/E Ratio
PEG15.74PEG
Price to Sales-Price to Sales
Price to Book Ratio-0.02Price to Book Ratio
Enterprise Value to Revenue-
Enterprise Value to EBIT-3.7
Enterprise Value to Net Income-4
Total Debt to Enterprise0.22
Debt to Equity-0.26Debt to Equity

Revenue Sources

No data

Institutional Sentiment (Put/Call)

No data available for the latest quarter.

Institutional Ownership

No data available for the latest quarter.

About Tanke Biosciences Corporation

130 employees
CEO: Vincent W. Renz Jr.

Tanke Biosciences Corporation (TNBI) is a company dedicated to the development, production, and sale of a diverse portfolio of animal nutrition and feed additive products through its various subsidiaries. The company organizes its busine...

Questions & Answers